<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ketendo</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая и экспериментальная тиреоидология</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical and experimental thyroidology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5472</issn><issn pub-type="epub">2310-3787</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/ket20084148-52</article-id><article-id custom-type="elpub" pub-id-type="custom">ketendo-4424</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>К ВОПРОСУ ЛЕЧЕНИЯ СУБКЛИНИЧЕСКОГО ГИПОТИРЕОЗА У БОЛЬНЫХ ОЖИРЕНИЕМ</article-title><trans-title-group xml:lang="en"><trans-title>Treatment of Subclinical Hypothyroidism in Obese Patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Demidova</surname><given-names>T</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Galieva</surname><given-names>O</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>15</day><month>03</month><year>2008</year></pub-date><volume>4</volume><issue>1</issue><issue-title>ТОМ 4, №1 (2008)</issue-title><fpage>48</fpage><lpage>52</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Demidova T., Galieva O., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Demidova T., Galieva O.</copyright-holder><copyright-holder xml:lang="en">Demidova T., Galieva O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cet-endojournals.ru/jour/article/view/4424">https://www.cet-endojournals.ru/jour/article/view/4424</self-uri><abstract><p>В исследование были включены 20 женщин, страдающих ожирением и субклиническим гипотиреозом. Проводили в динамике (исходно и через 6 мес после нормализации уровня ТТГ на фоне заместительной терапии L-L-T4) исследования липидного спектра, показатели углеводного обмена, АД и инсулинорезистентности, степень выраженности и варианты распределения жировой ткани, пробу с физической нагрузкой. Обнаруженные позитивные сдвиги при вышеперечисленных исследованиях позволили нам высказаться в пользу проведения заместительной терапии L-Т4 при СГ.</p></abstract><trans-abstract xml:lang="en"><p>We observed 20 women suffering from adiposity and subclinical hypothyroidism. Lipid spectrum, carbohydrate metabolism, BP and insulinresistance, the extent and variants of fat tissue distribution, a test with physical exercise, all research in dynamics (in the beginning and 6 months after normalization of TSH level against the background of substitution therapy with L-T4) were evaluated. The positive shifts revealed during the afore mentioned research allow us to express our opinion in favour of carrying out substitution therapy with L-T4 at subclinical hypothyroidism .</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Vanderpump M.P., Tunbridge W.M. Epidemiology and prevention of clinical and subclinical hypothyroidism // Thyroid. 2002. V. 12. P. 839—847.</mixed-citation><mixed-citation xml:lang="en">Vanderpump M.P., Tunbridge W.M. Epidemiology and prevention of clinical and subclinical hypothyroidism // Thyroid. 2002. V. 12. P. 839—847.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Vierhappes H. Assessment of thyroid gland function in unwanted infertility — indications for TRH test and clinical impact from the viewpoint of the endocrinologist // Acta Med. Austriaca. 1997. V. 24(4). P. 133—135.</mixed-citation><mixed-citation xml:lang="en">Vierhappes H. Assessment of thyroid gland function in unwanted infertility — indications for TRH test and clinical impact from the viewpoint of the endocrinologist // Acta Med. Austriaca. 1997. V. 24(4). P. 133—135.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Toft A. Thyroxine therapy // N. Engl. J. Med. 1994. V. 331(3). P. 174—180.</mixed-citation><mixed-citation xml:lang="en">Toft A. Thyroxine therapy // N. Engl. J. Med. 1994. V. 331(3). P. 174—180.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Сыч Ю.П. Заместительная терапия L-тироксином у пациентов с субклиническим гипотиреозом и ишемической болезнью сердца: Автореф.... канд. мед. наук. М., 2005.</mixed-citation><mixed-citation xml:lang="en">Сыч Ю.П. Заместительная терапия L-тироксином у пациентов с субклиническим гипотиреозом и ишемической болезнью сердца: Автореф.... канд. мед. наук. М., 2005.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Diez J., Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure // J. Clin. Endocrin. Met. 2004. V. 89. P. 4890—4897.</mixed-citation><mixed-citation xml:lang="en">Diez J., Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure // J. Clin. Endocrin. Met. 2004. V. 89. P. 4890—4897.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мельниченко Г.А. Аутоиммунный тиреоидит: клинические рекомендации российской ассоциации эндокринологов: В кн. “Актуальные проблемы щитовидной железы” // Матер. 2-го Всерос. тиреоидол. конгр., 20—21 ноября 2002. М., 2002. С. 5—18.</mixed-citation><mixed-citation xml:lang="en">Мельниченко Г.А. Аутоиммунный тиреоидит: клинические рекомендации российской ассоциации эндокринологов: В кн. “Актуальные проблемы щитовидной железы” // Матер. 2-го Всерос. тиреоидол. конгр., 20—21 ноября 2002. М., 2002. С. 5—18.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hak A.E., Pols H., Visser T.J. et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study // Ann. Intern. Med. 2000. V. 132. P. 270—278.</mixed-citation><mixed-citation xml:lang="en">Hak A.E., Pols H., Visser T.J. et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study // Ann. Intern. Med. 2000. V. 132. P. 270—278.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Walsh J.P., Bremmner A.P., Bulsara M.K. et al. Subclinical thyroid dysfunction as a risk factor cardiovascular disease // Arch. Intern. Med. 2005. V. 165. P. 2467—2472.</mixed-citation><mixed-citation xml:lang="en">Walsh J.P., Bremmner A.P., Bulsara M.K. et al. Subclinical thyroid dysfunction as a risk factor cardiovascular disease // Arch. Intern. Med. 2005. V. 165. P. 2467—2472.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rodondi N., Aujesky D., Vittinghoff E., Cornuz J. et al. Subclinical hypothyroidism and the risk of coronary heart disease: a metaanalysis // Am. J. Med. 2006. V. 119. P. 541—551.</mixed-citation><mixed-citation xml:lang="en">Rodondi N., Aujesky D., Vittinghoff E., Cornuz J. et al. Subclinical hypothyroidism and the risk of coronary heart disease: a metaanalysis // Am. J. Med. 2006. V. 119. P. 541—551.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ridgway E.C., Cooper D.S., Walker H. et al. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism // J. Clin. Endocrin. Met. 1981. V. 53. P. 1238.</mixed-citation><mixed-citation xml:lang="en">Ridgway E.C., Cooper D.S., Walker H. et al. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism // J. Clin. Endocrin. Met. 1981. V. 53. P. 1238.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Efstathiadou Z., Bitsis S., Milionis H.J. et al. Lipid profile in sub-clinical hypothyroidism: is L-thyroxine substitution beneficial? // Eur. J. Endocrin. 2001. V. 145. P. 705—710.</mixed-citation><mixed-citation xml:lang="en">Efstathiadou Z., Bitsis S., Milionis H.J. et al. Lipid profile in sub-clinical hypothyroidism: is L-thyroxine substitution beneficial? // Eur. J. Endocrin. 2001. V. 145. P. 705—710.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Danese M.D., Ladenson P.W., Meinert C.L. et al. Eeffect of thyroxin therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature // J. Clin. Endocrin. Met. 2000. V. 85. P. 2993—3001.</mixed-citation><mixed-citation xml:lang="en">Danese M.D., Ladenson P.W., Meinert C.L. et al. Eeffect of thyroxin therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature // J. Clin. Endocrin. Met. 2000. V. 85. P. 2993—3001.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Caraccio N., Ferrannini E., Monzani F. Lipoprotein profile in sub-clinical hypothyroidism: response to levothyroxine replacement; Ridgway E.C., Cooper D.S., Walker H. et al. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism // J. Clin. Endocrin. Met. 1981. V. 53. P.1238.</mixed-citation><mixed-citation xml:lang="en">Caraccio N., Ferrannini E., Monzani F. Lipoprotein profile in sub-clinical hypothyroidism: response to levothyroxine replacement; Ridgway E.C., Cooper D.S., Walker H. et al. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism // J. Clin. Endocrin. Met. 1981. V. 53. P.1238.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
